| Amniotic membrane transplantation for the treatment of ocular burns |
| Amniotomy alone for induction of labour |
| Amniotomy for shortening spontaneous labour |
| Amniotomy for shortening spontaneous labour |
| Amniotomy plus intravenous oxytocin for induction of labour |
| Amniotomy plus intravenous oxytocin for induction of labour |
| Amodiaquine for treating malaria |
| Amphetamines for attention deficit hyperactivity disorder in adults |
| Amphetamines for attention deficit hyperactivity disorder in children and adolescents |
| Amphetamines for improving recovery after stroke |
| Amphetamines for schizophrenia |
| Amphetamines versus placebo for schizophrenia |
| Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function |
| Amplitude-integrated electroencephalography compared with conventional video-electroencephalography for detection of neonatal seizures |
| Amylase in drain fluid for the diagnosis of pancreatic leak after partial removal of the pancreas |
| An analysis in Australia’s The Age newspaper cites multiple Cochrane Reviews |
| An assessment of the effectiveness and safety of a treatment used for children with encephalitis |
| An international network for public involvement and engagement in health and social care research |
| An interview on consumer involvement in research with Simon Denegri, NIHR |
| An Interview with Doug Altman |
| An Open Letter in Response to the FDA’s Public Comment Request on the Clinical Data Summary Report Pilot |
| An overview of Cochrane Reviews on red blood cell transfusions to treat or prevent sickle cell disease-related complications |
| An overview of systematic reviews on mental health interventions for involuntary migrants |
| Anabolic steroids for improving recovery after hip fracture in older people |
| Anabolic steroids for the treatment of weight loss in HIV-infected individuals |
| Anabolic steroids for treating pressure ulcers |
| Anaesthesia and analgesia in the emergency care setting for treating distal radius fractures in adults |
| Anaesthesia for cardioversion |
| Anaesthesia for hand and forearm surgery via single, double or multiple injections placed close to nerves in the armpit |
| Anaesthesia for surgical evacuation of an incomplete miscarriage |
| Anaesthesia for treating distal radial fracture in adults |
| Anaesthesia or analgesia during the manual removal of a retained placenta |
| Anaesthesia with injectable versus gaseous anaesthetic agents for rapid awakening following surgery for brain tumour |
| Anaesthetic drugs for cardioversion |
| Anaesthetic regimens for day-procedure laparoscopic cholecystectomy |
| Anaesthetic techniques for open inguinal and femoral hernia repair in adults |
| Anaesthetic techniques for risk of malignant tumour recurrence |
| Anakinra for Rheumatoid Arthritis |
| Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip |
| Analgesia for amniocentesis |
| Analgesia for forceps delivery |
| Analgesia for patients undergoing shockwave lithotripsy for urinary stones |
| Analgesic effects of antipsychotics in acute and chronic painful states |
| Analgesics for intrauterine device placement |
| Analgesics for postoperative pain after tonsillectomy and adenoidectomy in children |
| Analgesics for postoperative pain after tonsillectomy and adenoidectomy in children |
| Anastomosis to stomach versus anastomosis to jejunum for reconstructing the pancreatic stump after pancreatoduodenectomy |
| Anatomical iliofemoral bypass versus extra-anatomical crossover grafting for symptomatic unilateral iliac disease |
| Androgen suppression monotherapy for treatment of advanced prostate cancer |
| Androgen therapy for constitutional delay of growth and puberty in boys |
| Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease |
| Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction technology |
| Androgens for the anaemia of chronic kidney disease in adults |
| Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia |
| Angiogenesis-inhibitors for metastatic thyroid cancer |
| Angioplasty alone or with stenting for subclavian artery stenosis |
| Angioplasty and stenting for peripheral arterial disease of the lower limbs: an overview of Cochrane Reviews |
| Angioplasty for intracranial artery stenosis |
| Angioplasty versus angioplasty plus stenting for lesions of the superficial femoral artery |
| Angioplasty versus conservative management of intermittent claudication, leg pain on walking |
| Angioplasty versus stenting for below-knee arterial disease in people with chronic limb-threatening ischaemia |
| Angiotensin converting enzyme (ACE) gene polymorphism (ACEI/D) in hypertensive adults with ACE inhibitor-induced cough |
| Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension |
| Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension |
| Angiotensin converting enzyme inhibitors for heart failure |
| Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria |
| Angiotensin receptor blockers for the treatment of high blood pressure |
| Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers for preserving residual kidney function in peritoneal dialysis patients |
| Angiotensin-converting enzyme inhibitors for congestive heart failure in children |
| Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease |
| Animal derived surfactant compared to protein-free synthetic surfactant preparations in preterm infants that have or are at high risk for respiratory distress syndrome. |
| Animal derived surfactant extract treatment for respiratory distress syndrome |
| Animal-assisted therapy for people with dementia |
| Animal-assisted therapy for people with serious mental illness |
| Animal-assisted therapy, including animal-assisted activities and resident animals, for improving quality of life in people with stroke |
| Animal-source foods for growth and development in children 6 to 59 months of age |
| Animating COVID-19 Evidence: an interview with stop motion animator, Beth Adams |
| Ankle brachial index for the diagnosis of lower limb peripheral arterial disease |
| Ankle foot orthosis for walking in stroke rehabilitation |
| Ankle-foot orthoses to improve walking in people with weakness of the calf muscles due to neuromuscular disorders |
| Anne Anderson Award: recognizing the enhancement and visibility of women in Cochrane |
| Anne Anderson on Lifeology's Historic STEAM Heros card deck: artist interview |
| Announcing Cochrane Colloquium Edinburgh 2018: a Patients Included health research conference |
| Announcing Cochrane's new brand identity |
| Announcing the 2023 Cochrane Colloquium in London, UK |
| Announcing the appointment of Marguerite Koster as Governing Board Co-Chair |
| Announcing the Global Evidence Summit 2017 |
| Announcing the launch of the inaugural Cochrane Scientific Committee |
| Announcing the winners of the Rosamund Snow Prize |
| Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux Disease |
| Antacids, sucralfate and bismuth salts for functional dyspepsia |
| Antenatal abdominal decompression for maternal hypertension or impaired fetal growth |
| Antenatal breastfeeding education for increasing breastfeeding duration |
| Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviews |
| Antenatal day care units versus hospital admission for women with pregnancy complications |
| Antenatal dietary education and supplementation on energy and protein intake in pregnancy to improve infant outcomes |
| Antenatal education for self-diagnosis of the onset of active labour at term |
| Antenatal immunoglobulin for fetal red blood cell alloimmunization |
| Antenatal interventions for fetomaternal alloimmune thrombocytopenia |
| Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery |
| Antenatal perineal massage for reducing perineal trauma |
| Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization |
| Antenatal psychosocial assessment for reducing perinatal mental health morbidity |
| Antenatal screening for Down's syndrome: generic protocol |
| Antenatal screening tests for the prevention and treatment of syphilis |
| Anterior approach versus conventional liver resection for hepatocellular carcinoma |
| Anterior repositioning splint for temporomandibular joint disc displacement |
| Anterior vaginal repair for urinary incontinence in women |
| Anterior versus posterior approach for multilevel cervical spondylotic myelopathy |
| Anterior versus posterior mediastinal reconstruction after esophagectomy for patients with esophageal cancer |
| Anterior versus posterior spinal correction and fusion for adolescent idiopathic scoliosis |
| Anthelmintics for people with neurocysticercosis |
| Anthracyclines in the treatment of follicular lymphoma (FL) in adults |
| Anti Spastic Medication for Spasticity in Cerebral Palsy |
| Anti-adhesion treatment after hysteroscopy for women having difficulty becoming pregnant |
| Anti-anemia drugs shorten survival for some cancer patients |
| Anti-angiogenic therapy for lung cancer |
| Anti-cancer drug treatment for gestational trophoblastic neoplasia (GTN) that does not respond to first-line treatment or that re-occurs |
| Anti-cytokine and anti-endotoxin therapies for meningococcal disease |
| Anti-D administration after childbirth for preventing Rhesus alloimmunisation |
| Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation |
| Anti-D administration in pregnancy for preventing Rhesus alloimmunisation |
| Anti-dementia drugs for people with memory problems but without dementia |
| Anti-depressant therapies may be able to help relieve depression in people with Parkinson's disease but more research is needed on safety and effectiveness. |
| Anti-depressants and centrally active agents for fibromyalgia syndrome |
| Anti-epidermal growth factor receptor (anti-EGFR) agents as adjuncts to conventional treatment for head and neck squamous cell carcinomas |
| Anti-epileptic drugs can reduce seizures after head injury, but more research is needed to establish whether this leads to a reduction in deaths or disability |
| Anti-epileptic drugs for preventing seizures in patients with long-term bleeding around the brain (subdural haematoma) |
| Anti-fibrinolytic drugs for reducing blood loss and the need for red blood cell transfusions during and after surgery. |
| Anti-GD2 antibody-containing immunotherapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation |
| Anti-GM1 antibody testing for multifocal motor neuropathy |
| Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies |
| Anti-histamines for prolonged non-specific cough in children |
| Anti-IL-17 monoclonal antibody for induction of remission in Crohn's disease |
| Anti-IL5 therapies for chronic obstructive pulmonary disease |
| Anti-inflammatory drugs for acute low back pain |
| Anti-inflammatory drugs for relief of perineal pain after childbirth |
| Anti-inflammatory medications for the treatment of obstructive sleep apnoea in children |
| Anti-inflammatory medications for preventing major heart events and strokes following ischaemic stroke (stroke due to a clot) or mini-stroke |
| Anti-inflammatory treatment in the form of corticosteroids and immunotherapy to prevent heart damage resulting from rheumatic fever |
| Anti-interferon therapy for systemic lupus erythematosus |
| Anti-interleukin-13 or anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma |
| Anti-leukotriene agents compared to inhaled corticosteroids for people with asthma |
| Anti-MAdCAM antibody for induction of remission in ulcerative colitis |
| Anti-peptic ulcer treatments that cause the least severe complication of ventilated-associated pneumonia in critically ill patients |
| Anti-reflux treatment for signs and symptoms of laryngopharyngeal reflux |
| Anti-sclerostin antibodies for the treatment of osteoporosis |
| Anti-sickness medication for vomiting in acute stomach upsets in children |
| Anti-thymocyte globulins for the prevention of graft-versus-host disease in patients receiving a foreign stem cell transplantation |
| Anti-TNF agents for paediatric psoriasis |
| Anti-TNF-alpha drugs for treating ankylosing spondylitis |
| Anti-TNF-α drugs for women with endometriosis-related pelvic pain |
| Anti-tuberculous therapy for maintaining remission in Crohn's disease |
| Anti-tumour necrosis factor medication for treating swelling at the back of the eye (macular oedema) due to inflammatory eye disease (uveitis) |
| Anti-vascular endothelial growth factor (anti-VEGF) medicines for diabetic macular oedema |
| Anti-vascular endothelial growth factor (anti-VEGF) medicines for diabetic macular oedema |
| Anti-vascular endothelial growth factor (anti-VEGF) plus intravitreal steroids for diabetic macular oedema |
| Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity |
| Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery |
| Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion |
| Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion |
| Anti-vascular endothelial growth factor for neovascular age-related macular degeneration |
| Anti-vascular endothelial growth factor for neovascular glaucoma |
| Anti-VEGF for prevention of complications after vitrectomy for proliferative diabetic retinopathy |
| Anti-VEGF for treatment of choroidal neovascularisation (new blood vessels) in people with pathological (severe) myopia |
| Antiamoebic drugs for treating amoebic colitis |
| Antiandrogenic treatment for sexual disinhibition in male patients with dementia |
| Antiarrhythmics for maintaining sinus rhythm (normal heartbeat) after reversing atrial fibrillation (correcting an irregular heartbeat) |
| Antibacterial chlorhexidine applied to the vagina during labour to prevent early-onset group B streptococcal infection in the newborn |
| Antibiotic drugs for treating skin and soft tissue infections |
| Antibiotic duration for treating uncomplicated symptomatic lower urinary tract infection in elderly women |
| Antibiotic ear drops can clear up children's suppurative otitis media (glue ear), but antiseptics and oral or injected antibiotics may not work as well |
| Antibiotic enhancing treatment for lung infections in cystic fibrosis |
| Antibiotic lock to prevent catheter infection in infants |
| Antibiotic prophylaxis could be considered for routine in emergency appendectomies. |
| Antibiotic prophylaxis during the second and third trimester in pregnancy to reduce adverse pregnancy outcomes and morbidity |
| Antibiotic prophylaxis for elective gallbladder surgery |
| Antibiotic prophylaxis for elective hysterectomy |
| Antibiotic prophylaxis for first trimester induced abortion |
| Antibiotic prophylaxis for people with cirrhosis and variceal bleeding |
| Antibiotic prophylaxis for prevention of bacterial infections and death in cirrhotic patients with upper gastrointestinal bleeding |
| Antibiotic prophylaxis for prevention of postoperative wound infection in adults undergoing open elective inguinal or femoral hernia repair |
| Antibiotic prophylaxis for short-term catheter bladder drainage in adults |
| Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures |
| Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation |
| Antibiotic prophylaxis for third- and fourth-degree perineal tear during vaginal birth |
| Antibiotic prophylaxis for transrectal prostate biopsy |
| Antibiotic prophylaxis for transurethral urological procedures |
| Antibiotic prophylaxis regimens and drugs for cesarean section |
| Antibiotic prophylaxis versus placebo or no intervention for people with cirrhosis and variceal bleeding |
| Antibiotic regimens for early-onset neonatal sepsis |
| Antibiotic regimens for late-onset neonatal sepsis |
| Antibiotic regimens for management of intraamniotic infection |
| Antibiotic regimens for postpartum endometritis |
| Antibiotic regimens for suspected early neonatal sepsis |
| Antibiotic regimens for suspected late onset sepsis in newborn infants |
| Antibiotic therapy for adults with neurosyphilis |
| Antibiotic therapy for Clostridium difficile-associated diarrhoea in adults |
| Antibiotic therapy for preventing infections in people with acute stroke |
| Antibiotic therapy for Shigella dysentery |
| Antibiotic therapy for the treatment of infective endocarditis |
| Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in people with surgical wounds |
| Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA)-infected or colonised non surgical wounds |
| Antibiotic treatment for asymptomatic bacteriuria |
| Antibiotic treatment for low back pain or radicular pain, or both |
| Antibiotic treatment for nontuberculous mycobacteria in people with cystic fibrosis |
| Antibiotic treatment for people with acute bronchitis |
| Antibiotic treatment for spontaneous bacterial peritonitis in people with advanced liver disease |
| Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis |
| Antibiotic treatment for the prevention of Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients |
| Antibiotic treatment for the sexual partners of women with bacterial vaginosis |
| Antibiotic treatment for ventilated patients with pneumonia |
| Antibiotic treatment reduces duration and severity of travellers' diarrhoea. |
| Antibiotic treatment to reduce the duration and severity of travellers’ diarrhoea |
| Antibiotic treatments for long-term Burkholderia cepacia infections in people with cystic fibrosis |
| Antibiotic usage for necrotising enterocolitis in newborn infants |
| Antibiotic use before amniotomy (artificially rupturing the membranes) for reducing infections in mother and infant |
| Antibiotic use for severe toothache (irreversible pulpitis) |
| Antibiotic-coated sutures versus non-antibiotic-coated sutures for the prevention of abdominal surgical wound infection |
| Antibiotics administered to patients prior to colorectal surgery |
| Antibiotics and antiseptics for pressure ulcers |
| Antibiotics and antiseptics for preventing infection in people receiving primary total joint prostheses (replacements) |
| Antibiotics and antiseptics for surgical wounds healing by secondary intention |
| Antibiotics and antiseptics to help healing venous leg ulcers |
| Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery |
| Antibiotics and antivirals for dementia and mild cognitive impairment |
| Antibiotics are effective in preventing post-operative complications following infection of the peritoneum (peritonitis), but there is no evidence to support that one regimen is superior to another, and at the same time has less side effects. |
| Antibiotics at the time of cataract surgery to prevent bacterial infection of the eye |
| Antibiotics at the time of removal of a central line to reduce complications in newborn infants |
| Antibiotics can sometimes stop persistent runny noses in children, but there is no evidence of long term benefit |
| Antibiotics compared with no treatment or placebo for the treatment of toxoplasma retinochoroiditis |
| Antibiotics delivered in the home or clinic for newborns with suspected, serious infections in low- and middle-income countries |
| Antibiotics for acute maxillary sinusitis |
| Antibiotics for acute middle ear infection (acute otitis media) in children |
| Antibiotics for acute middle ear infection (acute otitis media) in children |
| Antibiotics for acute pyelonephritis in adults |
| Antibiotics for adults and children with sore throats |
| Antibiotics for adults with acute cholecystitis or acute cholangitis or both |
| Antibiotics for bacteraemia due to |
| Antibiotics for bacterial infection in the urine in kidney transplant recipients when there are no symptoms |
| Antibiotics for bacterial infection in the urine in pregnancy when there are no symptoms |
| Antibiotics for brain abscesses in people with cyanotic congenital heart disease |
| Antibiotics for bronchiolitis in children under two years of age |
| Antibiotics for children with a neurodisability and long-term lung infection |
| Antibiotics for cholangitis and/or cholecystitis |
| Antibiotics for common respiratory infections with unclear causes and undifferentiated symptoms in children up to five years of age |
| Antibiotics for community-acquired pneumonia in adolescent and adult outpatients |
| Antibiotics for covert bacteriuria in children |
| Antibiotics for gonorrhoea in pregnancy |
| Antibiotics for hepatic encephalopathy |
